93 related articles for article (PubMed ID: 16515897)
1. Anticoagulation for cardiopulmonary bypass: is a replacement for heparin on the horizon?
Warkentin TE
J Thorac Cardiovasc Surg; 2006 Mar; 131(3):515-6. PubMed ID: 16515897
[No Abstract] [Full Text] [Related]
2. Novel techniques in the use of bivalirudin for cardiopulmonary bypass anticoagulation in a child with heparin-induced thrombocytopenia.
Dragomer D; Chalfant A; Biniwale R; Reemtsen B; Federman M
Perfusion; 2011 Nov; 26(6):516-8. PubMed ID: 21828161
[TBL] [Abstract][Full Text] [Related]
3. Cardiopulmonary bypass with bivalirudin in type II heparin-induced thrombocytopenia.
Clayton SB; Acsell JR; Crumbley AJ; Uber WE
Ann Thorac Surg; 2004 Dec; 78(6):2167-9. PubMed ID: 15561064
[TBL] [Abstract][Full Text] [Related]
4. Anticoagulation with bivalirudin during cardiopulmonary bypass in cardiac surgery.
Vasquez JC; Vichiendilokkul A; Mahmood S; Baciewicz FA
Ann Thorac Surg; 2002 Dec; 74(6):2177-9. PubMed ID: 12643418
[TBL] [Abstract][Full Text] [Related]
5. Case 1-2006: off-pump coronary artery bypass graft surgery anticoagulation with bivalirudin: a patient with heparin-induced thrombocytopenia syndrome type II and renal failure.
Spiess BD; DeAnda A; McCarthy HL; Yeatman D; Katlaps G; Cooper C; Koster A; Aldea GS; Gravlee GP
J Cardiothorac Vasc Anesth; 2006 Feb; 20(1):106-11. PubMed ID: 16458228
[No Abstract] [Full Text] [Related]
6. Successful use of bivalirudin for cardiopulmonary bypass in a patient with heparin-induced thrombocytopenia.
Gordon G; Rastegar H; Schumann R; Deiss-Shrem J; Denman W
J Cardiothorac Vasc Anesth; 2003 Oct; 17(5):632-5. PubMed ID: 14579220
[No Abstract] [Full Text] [Related]
7. Anticoagulant monitoring techniques in a heparin-induced thrombocytopenia patient undergoing cardiopulmonary bypass using bivalirudin anticoagulant.
Baker T; Chan R; Hill F
J Extra Corpor Technol; 2004 Dec; 36(4):371-4. PubMed ID: 15679282
[TBL] [Abstract][Full Text] [Related]
8. Bivalirudin: alternative anticoagulation during cardiopulmonary bypass in patients with heparin-induced thrombocytopenia.
Grubb KJ; Salehi P; Chedrawy EG
Recent Pat Cardiovasc Drug Discov; 2010 Jan; 5(1):20-4. PubMed ID: 19903167
[TBL] [Abstract][Full Text] [Related]
9. Bivalirudin anticoagulation for cardiopulmonary bypass: an unusual case.
Nikolaidis N; Velissaris T; Ohri SK
Tex Heart Inst J; 2007; 34(1):115-8. PubMed ID: 17420808
[TBL] [Abstract][Full Text] [Related]
10. Successful use of bivalirudin for cardiac transplantation in a child with heparin-induced thrombocytopenia.
Almond CS; Harrington J; Thiagarajan R; Duncan CN; LaPierre R; Halwick D; Blume ED; Del Nido PJ; Neufeld EJ; McGowan FX
J Heart Lung Transplant; 2006 Nov; 25(11):1376-9. PubMed ID: 17097505
[TBL] [Abstract][Full Text] [Related]
11. Successful use of bivalirudin for combined carotid endarterectomy and coronary revascularization with the use of cardiopulmonary bypass in a patient with an elevated heparin-platelet factor 4 antibody titer.
Avery EG; Hilgenberg AD; Cambria RP; Beckerly R; Donnelly AM; Laposata M
Anesth Analg; 2009 Apr; 108(4):1113-5. PubMed ID: 19299772
[TBL] [Abstract][Full Text] [Related]
12. Heart transplantation using bivalirudin as anticoagulant.
Simsir SA; Schwarz ER; Czer LS; Hamburg SI
Interact Cardiovasc Thorac Surg; 2010 Jan; 10(1):150-1. PubMed ID: 19797475
[TBL] [Abstract][Full Text] [Related]
13. Bivalirudin Anticoagulation for a Pediatric Patient with Heparin-Induced Thrombocytopenia and Thrombosis Requiring Cardiopulmonary Bypass for Ventricular Assist Device Placement.
Faella KH; Whiting D; Fynn-Thompson F; Matte GS
J Extra Corpor Technol; 2016 Mar; 48(1):39-42. PubMed ID: 27134308
[TBL] [Abstract][Full Text] [Related]
14. Bivalirudin anticoagulation for cardiopulmonary bypass in a patient with heparin-induced thrombocytopenia.
Wasowicz M; Vegas A; Borger MA; Harwood S
Can J Anaesth; 2005 Dec; 52(10):1093-8. PubMed ID: 16326682
[TBL] [Abstract][Full Text] [Related]
15. Bivalirudin during cardiopulmonary bypass in patients with previous or acute heparin-induced thrombocytopenia and heparin antibodies: results of the CHOOSE-ON trial.
Koster A; Dyke CM; Aldea G; Smedira NG; McCarthy HL; Aronson S; Hetzer R; Avery E; Spiess B; Lincoff AM
Ann Thorac Surg; 2007 Feb; 83(2):572-7. PubMed ID: 17257990
[TBL] [Abstract][Full Text] [Related]
16. Preemptive use of bivalirudin for urgent on-pump coronary artery bypass grafting in patients with potential heparin-induced thrombocytopenia.
Dyke CM; Koster A; Veale JJ; Maier GW; McNiff T; Levy JH
Ann Thorac Surg; 2005 Jul; 80(1):299-303. PubMed ID: 15975385
[TBL] [Abstract][Full Text] [Related]
17. A comparison of bivalirudin to heparin with protamine reversal in patients undergoing cardiac surgery with cardiopulmonary bypass: the EVOLUTION-ON study.
Dyke CM; Smedira NG; Koster A; Aronson S; McCarthy HL; Kirshner R; Lincoff AM; Spiess BD
J Thorac Cardiovasc Surg; 2006 Mar; 131(3):533-9. PubMed ID: 16515902
[TBL] [Abstract][Full Text] [Related]
18. Invited commentary.
Merry AF
Ann Thorac Surg; 2007 Sep; 84(3):840. PubMed ID: 17720386
[No Abstract] [Full Text] [Related]
19. Plasma-modified ACT can be used to monitor bivalirudin (Angiomax) anticoagulation for on-pump cardiopulmonary bypass surgery in a patient with heparin-induced thrombocytopenia.
Jabr K; Johnson JH; McDonald MH; Walsh DL; Martin WD; Johnson AC; Pickett JM; Shantha-Martin U
J Extra Corpor Technol; 2004 Jun; 36(2):174-7. PubMed ID: 15334761
[TBL] [Abstract][Full Text] [Related]
20. Invited commentary.
Moten SC; Buxton B
Ann Thorac Surg; 2005 Jul; 80(1):303. PubMed ID: 15975386
[No Abstract] [Full Text] [Related]
[Next] [New Search]
